Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tandem Mass Spectrometry | 13 | 2024 | 1156 | 2.180 |
Why?
|
Chromatography, High Pressure Liquid | 8 | 2024 | 1580 | 1.630 |
Why?
|
Chromatography, Liquid | 9 | 2024 | 977 | 1.410 |
Why?
|
Busulfan | 3 | 2020 | 262 | 0.950 |
Why?
|
Hyperammonemia | 3 | 2013 | 76 | 0.940 |
Why?
|
Immunoassay | 8 | 2021 | 750 | 0.910 |
Why?
|
Hypokalemia | 1 | 2023 | 154 | 0.860 |
Why?
|
Blood Chemical Analysis | 3 | 2013 | 441 | 0.780 |
Why?
|
Hemolysis | 2 | 2023 | 420 | 0.760 |
Why?
|
Chemistry, Clinical | 2 | 2015 | 64 | 0.760 |
Why?
|
Caffeine | 4 | 2013 | 697 | 0.720 |
Why?
|
Saxitoxin | 2 | 2016 | 65 | 0.700 |
Why?
|
Jaundice | 1 | 2018 | 89 | 0.650 |
Why?
|
Alcoholic Intoxication | 1 | 2018 | 188 | 0.610 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 3 | 2022 | 277 | 0.590 |
Why?
|
Amino Acids | 4 | 2013 | 1727 | 0.580 |
Why?
|
Cotinine | 4 | 2015 | 205 | 0.560 |
Why?
|
Anticonvulsants | 3 | 2024 | 1907 | 0.540 |
Why?
|
Neuromuscular Blocking Agents | 1 | 2016 | 130 | 0.530 |
Why?
|
Acetaminophen | 1 | 2018 | 541 | 0.490 |
Why?
|
25-Hydroxyvitamin D 2 | 2 | 2020 | 39 | 0.490 |
Why?
|
Theobromine | 2 | 2013 | 15 | 0.480 |
Why?
|
Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2013 | 23 | 0.480 |
Why?
|
gamma-Glutamyl Hydrolase | 2 | 2010 | 9 | 0.470 |
Why?
|
Methotrexate | 2 | 2010 | 1711 | 0.460 |
Why?
|
Hyperlipidemias | 1 | 2018 | 785 | 0.460 |
Why?
|
Hyperargininemia | 1 | 2012 | 12 | 0.440 |
Why?
|
Resistance Training | 4 | 2018 | 164 | 0.420 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2014 | 213 | 0.420 |
Why?
|
Information Services | 1 | 2013 | 244 | 0.410 |
Why?
|
Argininosuccinic Aciduria | 1 | 2011 | 10 | 0.410 |
Why?
|
Epidemiologic Studies | 1 | 2015 | 677 | 0.400 |
Why?
|
Confusion | 1 | 2013 | 271 | 0.400 |
Why?
|
3-Hydroxybutyric Acid | 1 | 2011 | 88 | 0.390 |
Why?
|
Anesthetics | 1 | 2016 | 536 | 0.380 |
Why?
|
Saliva | 3 | 2014 | 805 | 0.370 |
Why?
|
Drug Discovery | 2 | 2019 | 1056 | 0.370 |
Why?
|
Wine | 1 | 2010 | 165 | 0.360 |
Why?
|
Access to Information | 1 | 2013 | 322 | 0.360 |
Why?
|
Bioterrorism | 2 | 2009 | 146 | 0.360 |
Why?
|
Lead | 2 | 2016 | 851 | 0.350 |
Why?
|
Food Contamination | 1 | 2010 | 187 | 0.340 |
Why?
|
Tryptophan | 1 | 2011 | 477 | 0.330 |
Why?
|
Cacao | 1 | 2009 | 98 | 0.330 |
Why?
|
Nephelometry and Turbidimetry | 1 | 2008 | 91 | 0.330 |
Why?
|
Affect | 4 | 2013 | 1475 | 0.320 |
Why?
|
Goiter | 1 | 2008 | 87 | 0.320 |
Why?
|
Antibodies, Heterophile | 1 | 2008 | 128 | 0.320 |
Why?
|
Epilepsy | 1 | 2024 | 3289 | 0.320 |
Why?
|
Lead Poisoning | 1 | 2010 | 304 | 0.310 |
Why?
|
Drug Industry | 1 | 2014 | 742 | 0.310 |
Why?
|
Health Services | 1 | 2013 | 757 | 0.310 |
Why?
|
Diabetic Ketoacidosis | 1 | 2011 | 246 | 0.310 |
Why?
|
Iodide Peroxidase | 2 | 2023 | 293 | 0.300 |
Why?
|
Cystatin C | 1 | 2008 | 250 | 0.300 |
Why?
|
Drug Monitoring | 3 | 2024 | 961 | 0.290 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2010 | 640 | 0.290 |
Why?
|
Dehydration | 2 | 2005 | 230 | 0.290 |
Why?
|
Galactosemias | 3 | 2014 | 125 | 0.280 |
Why?
|
Interleukin-1beta | 1 | 2012 | 970 | 0.280 |
Why?
|
Artifacts | 2 | 2012 | 1905 | 0.280 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2010 | 628 | 0.280 |
Why?
|
Reproducibility of Results | 13 | 2024 | 19811 | 0.270 |
Why?
|
Osteosarcoma | 1 | 2010 | 884 | 0.250 |
Why?
|
Chemistry Techniques, Analytical | 1 | 2005 | 49 | 0.250 |
Why?
|
Information Dissemination | 1 | 2013 | 1106 | 0.250 |
Why?
|
Thyrotropin | 1 | 2008 | 849 | 0.250 |
Why?
|
Limit of Detection | 3 | 2016 | 264 | 0.240 |
Why?
|
Body Water | 1 | 2005 | 342 | 0.240 |
Why?
|
Water-Electrolyte Balance | 1 | 2005 | 345 | 0.240 |
Why?
|
Interferon-gamma | 1 | 2012 | 3193 | 0.230 |
Why?
|
Interleukin-6 | 2 | 2014 | 3194 | 0.220 |
Why?
|
Vitamin D | 2 | 2017 | 3197 | 0.220 |
Why?
|
False Positive Reactions | 2 | 2018 | 982 | 0.220 |
Why?
|
Pyomyositis | 1 | 2022 | 10 | 0.220 |
Why?
|
Phlebotomy | 1 | 2023 | 142 | 0.220 |
Why?
|
Tobacco Smoke Pollution | 4 | 2015 | 814 | 0.210 |
Why?
|
Humans | 77 | 2024 | 739398 | 0.210 |
Why?
|
Hodgkin Disease | 1 | 2010 | 1413 | 0.210 |
Why?
|
Thiocyanates | 1 | 2022 | 70 | 0.210 |
Why?
|
Chromatography, Ion Exchange | 2 | 2013 | 305 | 0.210 |
Why?
|
Milk Proteins | 2 | 2013 | 168 | 0.200 |
Why?
|
Central Nervous System Stimulants | 2 | 2013 | 1146 | 0.200 |
Why?
|
Homocysteine | 1 | 2005 | 647 | 0.200 |
Why?
|
Human Growth Hormone | 2 | 2018 | 683 | 0.200 |
Why?
|
Calibration | 3 | 2021 | 818 | 0.200 |
Why?
|
Neural Cell Adhesion Molecules | 1 | 2021 | 126 | 0.190 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2012 | 4400 | 0.190 |
Why?
|
UTP-Hexose-1-Phosphate Uridylyltransferase | 2 | 2010 | 68 | 0.180 |
Why?
|
Acidosis | 1 | 2022 | 273 | 0.180 |
Why?
|
High-Throughput Screening Assays | 2 | 2019 | 953 | 0.180 |
Why?
|
Dietary Supplements | 4 | 2016 | 3279 | 0.180 |
Why?
|
Attention | 3 | 2013 | 2400 | 0.180 |
Why?
|
Baths | 1 | 2019 | 54 | 0.180 |
Why?
|
Choice Behavior | 1 | 2005 | 801 | 0.170 |
Why?
|
Sweetening Agents | 2 | 2012 | 296 | 0.170 |
Why?
|
X-Linked Inhibitor of Apoptosis Protein | 1 | 2019 | 63 | 0.170 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 7897 | 0.170 |
Why?
|
Skin Diseases, Bacterial | 1 | 2019 | 66 | 0.170 |
Why?
|
Gastrointestinal Hormones | 1 | 2019 | 97 | 0.170 |
Why?
|
Exercise | 5 | 2018 | 5591 | 0.170 |
Why?
|
Erythrocyte Count | 1 | 2019 | 164 | 0.160 |
Why?
|
Gas Chromatography-Mass Spectrometry | 2 | 2017 | 361 | 0.160 |
Why?
|
Hemoglobins | 2 | 2019 | 1529 | 0.160 |
Why?
|
Seizures | 1 | 2011 | 2829 | 0.160 |
Why?
|
Bone Neoplasms | 1 | 2010 | 2521 | 0.160 |
Why?
|
Chlorhexidine | 1 | 2019 | 161 | 0.160 |
Why?
|
Beverages | 3 | 2013 | 817 | 0.160 |
Why?
|
Arthritis, Infectious | 1 | 2022 | 363 | 0.160 |
Why?
|
Erythrocyte Indices | 1 | 2019 | 146 | 0.160 |
Why?
|
Osteomyelitis | 1 | 2022 | 398 | 0.160 |
Why?
|
Acute Kidney Injury | 1 | 2010 | 1941 | 0.160 |
Why?
|
Energy Intake | 3 | 2014 | 2135 | 0.160 |
Why?
|
Metabolism, Inborn Errors | 1 | 2020 | 288 | 0.160 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2017 | 3863 | 0.150 |
Why?
|
Osmolar Concentration | 1 | 2018 | 683 | 0.150 |
Why?
|
Body Composition | 6 | 2011 | 2397 | 0.150 |
Why?
|
Cyanosis | 1 | 2017 | 83 | 0.150 |
Why?
|
Adolescent | 16 | 2022 | 85405 | 0.150 |
Why?
|
Hematocrit | 1 | 2019 | 636 | 0.150 |
Why?
|
Citrulline | 2 | 2014 | 105 | 0.150 |
Why?
|
Ginkgo biloba | 1 | 2016 | 26 | 0.150 |
Why?
|
Anti-Infective Agents, Local | 1 | 2019 | 248 | 0.150 |
Why?
|
Prostatic Hyperplasia | 1 | 2021 | 522 | 0.150 |
Why?
|
Diapers, Infant | 1 | 2016 | 3 | 0.150 |
Why?
|
Caloric Restriction | 2 | 2011 | 303 | 0.150 |
Why?
|
Hormones | 1 | 2021 | 880 | 0.150 |
Why?
|
Patients | 1 | 2023 | 890 | 0.150 |
Why?
|
Solid Phase Extraction | 1 | 2016 | 28 | 0.150 |
Why?
|
Visual Perception | 1 | 2005 | 1418 | 0.140 |
Why?
|
Vitamin A | 1 | 2020 | 613 | 0.140 |
Why?
|
Disulfides | 1 | 2018 | 458 | 0.140 |
Why?
|
Oxyhemoglobins | 1 | 2017 | 216 | 0.140 |
Why?
|
Catheter-Related Infections | 1 | 2019 | 253 | 0.140 |
Why?
|
Milk, Human | 1 | 2021 | 490 | 0.140 |
Why?
|
Blood Gas Analysis | 1 | 2017 | 380 | 0.140 |
Why?
|
Lyme Disease | 1 | 2022 | 612 | 0.140 |
Why?
|
Cannabinoids | 1 | 2018 | 167 | 0.140 |
Why?
|
Medicine, Traditional | 1 | 2016 | 90 | 0.140 |
Why?
|
Flagellin | 1 | 2017 | 125 | 0.140 |
Why?
|
Musculoskeletal Diseases | 1 | 2022 | 580 | 0.140 |
Why?
|
Military Personnel | 5 | 2011 | 1119 | 0.140 |
Why?
|
Male | 40 | 2021 | 349022 | 0.140 |
Why?
|
Vitamin E | 1 | 2020 | 870 | 0.130 |
Why?
|
Genetic Diseases, Inborn | 1 | 2020 | 588 | 0.130 |
Why?
|
Delivery of Health Care | 1 | 2013 | 5272 | 0.130 |
Why?
|
Nutrition Surveys | 2 | 2019 | 1645 | 0.130 |
Why?
|
Liver Diseases, Alcoholic | 1 | 2016 | 161 | 0.120 |
Why?
|
Autoantibodies | 1 | 2023 | 2020 | 0.120 |
Why?
|
UDPglucose 4-Epimerase | 1 | 2014 | 16 | 0.120 |
Why?
|
Muscle Strength | 1 | 2018 | 582 | 0.120 |
Why?
|
Reference Standards | 3 | 2020 | 1018 | 0.120 |
Why?
|
Oximetry | 1 | 2017 | 465 | 0.120 |
Why?
|
Eating | 1 | 2021 | 1526 | 0.120 |
Why?
|
Insulin-Like Growth Factor I | 3 | 2008 | 2015 | 0.120 |
Why?
|
Infant | 11 | 2021 | 34923 | 0.120 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2019 | 1157 | 0.120 |
Why?
|
Double-Blind Method | 9 | 2015 | 11985 | 0.120 |
Why?
|
Enteral Nutrition | 1 | 2019 | 758 | 0.120 |
Why?
|
Dehydroepiandrosterone Sulfate | 2 | 2011 | 238 | 0.110 |
Why?
|
Anesthesia, Local | 1 | 2015 | 265 | 0.110 |
Why?
|
Plant Extracts | 1 | 2016 | 464 | 0.110 |
Why?
|
Mucositis | 1 | 2014 | 101 | 0.110 |
Why?
|
Immunoglobulin A | 1 | 2017 | 989 | 0.110 |
Why?
|
Protein Hydrolysates | 1 | 2012 | 7 | 0.110 |
Why?
|
Mitochondrial Proteins | 1 | 2019 | 989 | 0.110 |
Why?
|
Malabsorption Syndromes | 1 | 2013 | 135 | 0.110 |
Why?
|
Liver Regeneration | 1 | 2014 | 209 | 0.110 |
Why?
|
Enzyme Assays | 2 | 2010 | 111 | 0.110 |
Why?
|
Specimen Handling | 2 | 2023 | 692 | 0.100 |
Why?
|
Bupivacaine | 1 | 2015 | 409 | 0.100 |
Why?
|
Epinephrine | 1 | 2015 | 795 | 0.100 |
Why?
|
Laboratories | 2 | 2020 | 458 | 0.100 |
Why?
|
Growth Disorders | 1 | 2017 | 644 | 0.100 |
Why?
|
Metabolomics | 1 | 2020 | 1460 | 0.100 |
Why?
|
Ammonia | 1 | 2012 | 240 | 0.100 |
Why?
|
Mouth Mucosa | 1 | 2014 | 430 | 0.100 |
Why?
|
Satiety Response | 1 | 2011 | 49 | 0.100 |
Why?
|
Alcohol Drinking | 2 | 2016 | 3945 | 0.100 |
Why?
|
Galactokinase | 1 | 2010 | 16 | 0.100 |
Why?
|
Bumetanide | 1 | 2011 | 95 | 0.090 |
Why?
|
Appetite Regulation | 1 | 2011 | 88 | 0.090 |
Why?
|
Food Deprivation | 2 | 2008 | 116 | 0.090 |
Why?
|
Reference Values | 4 | 2019 | 4983 | 0.090 |
Why?
|
Cross Infection | 1 | 2019 | 1414 | 0.090 |
Why?
|
Reaction Time | 2 | 2008 | 2097 | 0.090 |
Why?
|
Urea | 1 | 2012 | 448 | 0.090 |
Why?
|
Liver | 2 | 2016 | 7449 | 0.090 |
Why?
|
Adrenal Hyperplasia, Congenital | 1 | 2010 | 98 | 0.090 |
Why?
|
Xanthines | 1 | 2009 | 121 | 0.090 |
Why?
|
Gastrointestinal Diseases | 1 | 2018 | 1162 | 0.090 |
Why?
|
Diarrhea | 1 | 2017 | 1342 | 0.090 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2011 | 502 | 0.090 |
Why?
|
Kidney | 1 | 2005 | 7144 | 0.090 |
Why?
|
Child Development | 1 | 2021 | 2213 | 0.090 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2011 | 365 | 0.090 |
Why?
|
Vulnerable Populations | 1 | 2015 | 685 | 0.090 |
Why?
|
Zinc | 1 | 2013 | 683 | 0.080 |
Why?
|
Lipopolysaccharides | 1 | 2017 | 2208 | 0.080 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 1 | 2009 | 123 | 0.080 |
Why?
|
Ghrelin | 1 | 2011 | 266 | 0.080 |
Why?
|
Immunochemistry | 1 | 2008 | 125 | 0.080 |
Why?
|
Biochemical Phenomena | 1 | 2008 | 57 | 0.080 |
Why?
|
Leptin | 2 | 2021 | 1589 | 0.080 |
Why?
|
Sleep | 2 | 2018 | 4596 | 0.080 |
Why?
|
Anthrax | 1 | 2009 | 87 | 0.080 |
Why?
|
Anemia, Sideroblastic | 1 | 2009 | 101 | 0.080 |
Why?
|
Child | 12 | 2022 | 77033 | 0.080 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2009 | 230 | 0.080 |
Why?
|
Adult | 22 | 2019 | 213394 | 0.080 |
Why?
|
Cross-Over Studies | 5 | 2013 | 2030 | 0.080 |
Why?
|
Rheumatoid Factor | 1 | 2008 | 188 | 0.080 |
Why?
|
Mitochondrial Membrane Transport Proteins | 1 | 2009 | 154 | 0.080 |
Why?
|
Motor Activity | 2 | 2008 | 2719 | 0.080 |
Why?
|
Indicators and Reagents | 1 | 2008 | 460 | 0.080 |
Why?
|
Sensitivity and Specificity | 5 | 2017 | 14740 | 0.080 |
Why?
|
Thyroid Function Tests | 1 | 2008 | 284 | 0.080 |
Why?
|
Intestines | 1 | 2017 | 1919 | 0.080 |
Why?
|
Hepatocytes | 1 | 2014 | 1202 | 0.080 |
Why?
|
Arousal | 1 | 2013 | 1164 | 0.080 |
Why?
|
False Negative Reactions | 1 | 2008 | 589 | 0.070 |
Why?
|
Brain Chemistry | 1 | 2011 | 985 | 0.070 |
Why?
|
Dietary Proteins | 2 | 2013 | 959 | 0.070 |
Why?
|
Ciprofloxacin | 1 | 2009 | 313 | 0.070 |
Why?
|
Bilirubin | 1 | 2008 | 415 | 0.070 |
Why?
|
Neonatal Screening | 1 | 2011 | 591 | 0.070 |
Why?
|
Triiodothyronine | 1 | 2008 | 491 | 0.070 |
Why?
|
Critical Illness | 1 | 2019 | 2656 | 0.070 |
Why?
|
Observer Variation | 1 | 2012 | 2589 | 0.070 |
Why?
|
Immunosuppressive Agents | 2 | 2020 | 4143 | 0.070 |
Why?
|
Diagnosis, Differential | 1 | 2021 | 12948 | 0.070 |
Why?
|
ABO Blood-Group System | 1 | 2008 | 366 | 0.070 |
Why?
|
Asthma | 2 | 2015 | 5950 | 0.070 |
Why?
|
Sheep | 1 | 2008 | 1434 | 0.070 |
Why?
|
Fluorescence Polarization Immunoassay | 1 | 2005 | 9 | 0.070 |
Why?
|
Female | 26 | 2022 | 378853 | 0.070 |
Why?
|
Fat Emulsions, Intravenous | 1 | 2008 | 321 | 0.060 |
Why?
|
Heat Exhaustion | 1 | 2004 | 13 | 0.060 |
Why?
|
Blood Specimen Collection | 2 | 2023 | 246 | 0.060 |
Why?
|
Triglycerides | 2 | 2011 | 2447 | 0.060 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2014 | 5401 | 0.060 |
Why?
|
Fatigue | 1 | 2011 | 1524 | 0.060 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2008 | 1153 | 0.060 |
Why?
|
Creatine | 1 | 2006 | 422 | 0.060 |
Why?
|
Young Adult | 9 | 2019 | 56255 | 0.060 |
Why?
|
Child, Preschool | 6 | 2020 | 40802 | 0.060 |
Why?
|
Alberta | 1 | 2023 | 63 | 0.060 |
Why?
|
Renal Insufficiency | 1 | 2010 | 803 | 0.060 |
Why?
|
Suburban Population | 1 | 2023 | 54 | 0.060 |
Why?
|
Infant, Newborn | 4 | 2021 | 25470 | 0.060 |
Why?
|
Tanzania | 2 | 2018 | 1303 | 0.060 |
Why?
|
Poverty | 1 | 2015 | 2626 | 0.060 |
Why?
|
Kidney Function Tests | 1 | 2005 | 681 | 0.060 |
Why?
|
Paper | 1 | 2003 | 85 | 0.050 |
Why?
|
Monitoring, Physiologic | 1 | 2010 | 1735 | 0.050 |
Why?
|
Analysis of Variance | 5 | 2013 | 6370 | 0.050 |
Why?
|
Malonates | 1 | 2022 | 42 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2015 | 10945 | 0.050 |
Why?
|
Intestinal Mucosa | 1 | 2013 | 3036 | 0.050 |
Why?
|
Enzyme Stability | 2 | 2014 | 210 | 0.050 |
Why?
|
Succinates | 1 | 2022 | 83 | 0.050 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2004 | 249 | 0.050 |
Why?
|
Physical Endurance | 1 | 2004 | 370 | 0.050 |
Why?
|
Environmental Exposure | 1 | 2016 | 4220 | 0.050 |
Why?
|
Cyanides | 1 | 2022 | 83 | 0.050 |
Why?
|
Graft vs Host Disease | 1 | 2014 | 2945 | 0.050 |
Why?
|
Antidotes | 1 | 2022 | 138 | 0.050 |
Why?
|
Testosterone | 2 | 2010 | 2391 | 0.050 |
Why?
|
Overweight | 1 | 2012 | 2355 | 0.050 |
Why?
|
Denmark | 1 | 2023 | 730 | 0.050 |
Why?
|
Recurrence | 1 | 2012 | 8307 | 0.050 |
Why?
|
Immunoglobulin G | 1 | 2012 | 4522 | 0.050 |
Why?
|
Membrane Proteins | 1 | 2017 | 7862 | 0.050 |
Why?
|
Time Factors | 6 | 2014 | 40050 | 0.050 |
Why?
|
Antibodies, Monoclonal | 1 | 2017 | 9259 | 0.050 |
Why?
|
Glutarates | 1 | 2022 | 235 | 0.050 |
Why?
|
Sleep Deprivation | 1 | 2007 | 831 | 0.050 |
Why?
|
Endothelium, Vascular | 1 | 2012 | 4454 | 0.040 |
Why?
|
Patient Readmission | 1 | 2014 | 3106 | 0.040 |
Why?
|
Cognition | 2 | 2008 | 6686 | 0.040 |
Why?
|
Insulin | 2 | 2012 | 6569 | 0.040 |
Why?
|
Stress, Physiological | 1 | 2007 | 1405 | 0.040 |
Why?
|
Research Design | 1 | 2015 | 5959 | 0.040 |
Why?
|
Immunologic Factors | 1 | 2008 | 1571 | 0.040 |
Why?
|
Muscle, Skeletal | 3 | 2013 | 4920 | 0.040 |
Why?
|
Prostatic Neoplasms | 1 | 2021 | 10999 | 0.040 |
Why?
|
Infant Nutritional Physiological Phenomena | 1 | 2021 | 344 | 0.040 |
Why?
|
Quality Control | 1 | 2021 | 842 | 0.040 |
Why?
|
Regression Analysis | 2 | 2005 | 6452 | 0.040 |
Why?
|
Blood Glucose | 2 | 2011 | 6237 | 0.040 |
Why?
|
Gastric Emptying | 1 | 2019 | 232 | 0.040 |
Why?
|
Anxiety | 1 | 2011 | 4253 | 0.040 |
Why?
|
Campylobacter | 1 | 2017 | 59 | 0.040 |
Why?
|
Mass Spectrometry | 1 | 2004 | 2200 | 0.040 |
Why?
|
Enteropathogenic Escherichia coli | 1 | 2017 | 27 | 0.040 |
Why?
|
Drug Administration Schedule | 1 | 2005 | 4935 | 0.040 |
Why?
|
Electrochemical Techniques | 1 | 2017 | 98 | 0.040 |
Why?
|
Luminescence | 1 | 2017 | 136 | 0.040 |
Why?
|
Coronary Disease | 1 | 2012 | 6068 | 0.040 |
Why?
|
Clinical Enzyme Tests | 1 | 2016 | 114 | 0.040 |
Why?
|
Cohort Studies | 5 | 2021 | 40389 | 0.040 |
Why?
|
Luminescent Measurements | 1 | 2019 | 405 | 0.040 |
Why?
|
Powders | 1 | 2016 | 80 | 0.040 |
Why?
|
Cryptosporidium | 1 | 2017 | 44 | 0.040 |
Why?
|
Malaysia | 1 | 2016 | 92 | 0.040 |
Why?
|
Public Health | 1 | 2009 | 2587 | 0.040 |
Why?
|
Hospitalization | 2 | 2015 | 10208 | 0.040 |
Why?
|
Shigella | 1 | 2017 | 75 | 0.040 |
Why?
|
Plant Leaves | 1 | 2016 | 142 | 0.030 |
Why?
|
Electronic Health Records | 1 | 2013 | 4426 | 0.030 |
Why?
|
Plants, Medicinal | 1 | 2016 | 167 | 0.030 |
Why?
|
Consumer Product Safety | 1 | 2016 | 121 | 0.030 |
Why?
|
Psychomotor Performance | 1 | 2004 | 1899 | 0.030 |
Why?
|
Rotavirus | 1 | 2017 | 109 | 0.030 |
Why?
|
Placebos | 2 | 2012 | 1678 | 0.030 |
Why?
|
Hazardous Substances | 1 | 2016 | 149 | 0.030 |
Why?
|
Liver Function Tests | 1 | 2016 | 527 | 0.030 |
Why?
|
Workflow | 1 | 2020 | 831 | 0.030 |
Why?
|
Hypesthesia | 1 | 2015 | 110 | 0.030 |
Why?
|
Adiponectin | 1 | 2021 | 1096 | 0.030 |
Why?
|
Genome, Human | 1 | 2008 | 4419 | 0.030 |
Why?
|
Oxides | 1 | 2016 | 404 | 0.030 |
Why?
|
Phytotherapy | 1 | 2016 | 298 | 0.030 |
Why?
|
Carbon Tetrachloride | 1 | 2014 | 64 | 0.030 |
Why?
|
Ubiquitination | 1 | 2019 | 1003 | 0.030 |
Why?
|
Linear Models | 1 | 2005 | 5948 | 0.030 |
Why?
|
Toxins, Biological | 1 | 2014 | 66 | 0.030 |
Why?
|
Nutritional Status | 2 | 2017 | 1587 | 0.030 |
Why?
|
Ohio | 1 | 2015 | 337 | 0.030 |
Why?
|
Prospective Studies | 6 | 2015 | 53037 | 0.030 |
Why?
|
Zinc Sulfate | 1 | 2013 | 17 | 0.030 |
Why?
|
Lactulose | 1 | 2013 | 33 | 0.030 |
Why?
|
Syndrome | 1 | 2020 | 3241 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2018 | 1725 | 0.030 |
Why?
|
Burkina Faso | 1 | 2013 | 88 | 0.030 |
Why?
|
Hydrocortisone | 2 | 2011 | 1809 | 0.030 |
Why?
|
Prostate | 1 | 2021 | 1743 | 0.030 |
Why?
|
Calcium Signaling | 1 | 2017 | 721 | 0.030 |
Why?
|
Mannitol | 1 | 2013 | 181 | 0.030 |
Why?
|
Soybean Proteins | 1 | 2013 | 61 | 0.030 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2008 | 3636 | 0.030 |
Why?
|
Erythrocytes | 2 | 2014 | 2453 | 0.030 |
Why?
|
Middle Aged | 6 | 2021 | 212863 | 0.030 |
Why?
|
Cyclosporine | 1 | 2015 | 781 | 0.030 |
Why?
|
Intestinal Absorption | 1 | 2013 | 420 | 0.030 |
Why?
|
Depression | 1 | 2011 | 7689 | 0.030 |
Why?
|
Environment | 1 | 2018 | 1110 | 0.030 |
Why?
|
Intestinal Diseases | 1 | 2017 | 531 | 0.030 |
Why?
|
Body Weight | 2 | 2017 | 4660 | 0.030 |
Why?
|
Absorptiometry, Photon | 2 | 2008 | 1726 | 0.030 |
Why?
|
Infant, Premature | 1 | 2021 | 2039 | 0.030 |
Why?
|
Prostate-Specific Antigen | 1 | 2021 | 2441 | 0.030 |
Why?
|
Permeability | 1 | 2013 | 739 | 0.020 |
Why?
|
Tacrolimus | 1 | 2015 | 739 | 0.020 |
Why?
|
Leucine | 1 | 2013 | 560 | 0.020 |
Why?
|
Acetonitriles | 1 | 2011 | 51 | 0.020 |
Why?
|
Pregnanetriol | 1 | 2010 | 4 | 0.020 |
Why?
|
17-Ketosteroids | 1 | 2010 | 39 | 0.020 |
Why?
|
Weight Gain | 1 | 2021 | 2278 | 0.020 |
Why?
|
17-alpha-Hydroxyprogesterone | 1 | 2010 | 22 | 0.020 |
Why?
|
Feces | 1 | 2017 | 1389 | 0.020 |
Why?
|
Galactosephosphates | 1 | 2010 | 9 | 0.020 |
Why?
|
Aged | 4 | 2021 | 162698 | 0.020 |
Why?
|
Energy Metabolism | 3 | 2008 | 2896 | 0.020 |
Why?
|
Brachial Artery | 1 | 2012 | 370 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2009 | 7136 | 0.020 |
Why?
|
Mineralocorticoids | 1 | 2010 | 39 | 0.020 |
Why?
|
Androstenedione | 1 | 2010 | 131 | 0.020 |
Why?
|
Rats, Long-Evans | 1 | 2011 | 387 | 0.020 |
Why?
|
Least-Squares Analysis | 1 | 2011 | 382 | 0.020 |
Why?
|
Hemochromatosis | 1 | 2011 | 184 | 0.020 |
Why?
|
Necrosis | 1 | 2014 | 1643 | 0.020 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2011 | 403 | 0.020 |
Why?
|
Substrate Specificity | 1 | 2014 | 1798 | 0.020 |
Why?
|
Hospitals | 1 | 2023 | 3916 | 0.020 |
Why?
|
Catecholamines | 1 | 2010 | 387 | 0.020 |
Why?
|
Organ Specificity | 1 | 2014 | 2004 | 0.020 |
Why?
|
California | 1 | 2013 | 1400 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2019 | 6610 | 0.020 |
Why?
|
Isotope Labeling | 1 | 2011 | 415 | 0.020 |
Why?
|
Glycosylation | 1 | 2012 | 1125 | 0.020 |
Why?
|
Isoenzymes | 1 | 2014 | 1720 | 0.020 |
Why?
|
Molecular Structure | 1 | 2013 | 1925 | 0.020 |
Why?
|
Anesthetics, Local | 1 | 2015 | 987 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2017 | 4174 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8669 | 0.020 |
Why?
|
Yeasts | 1 | 2009 | 285 | 0.020 |
Why?
|
Phenotype | 2 | 2020 | 16301 | 0.020 |
Why?
|
Vasodilation | 1 | 2012 | 947 | 0.020 |
Why?
|
Dietary Carbohydrates | 1 | 2013 | 904 | 0.020 |
Why?
|
Sirolimus | 1 | 2015 | 1559 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2013 | 3146 | 0.020 |
Why?
|
Stress, Psychological | 1 | 2003 | 4212 | 0.020 |
Why?
|
Animals | 5 | 2014 | 168368 | 0.020 |
Why?
|
Diet, Reducing | 1 | 2011 | 460 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2012 | 57650 | 0.020 |
Why?
|
Muscle Proteins | 1 | 2013 | 1158 | 0.020 |
Why?
|
Genetic Testing | 1 | 2020 | 3441 | 0.020 |
Why?
|
Heme | 1 | 2009 | 306 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2017 | 6174 | 0.020 |
Why?
|
Physical Fitness | 1 | 2011 | 733 | 0.020 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2008 | 216 | 0.020 |
Why?
|
Bone Development | 1 | 2010 | 483 | 0.020 |
Why?
|
Solubility | 1 | 2008 | 1083 | 0.020 |
Why?
|
Aerosols | 1 | 2009 | 619 | 0.020 |
Why?
|
Muscle Fatigue | 1 | 2006 | 82 | 0.020 |
Why?
|
Pilot Projects | 1 | 2019 | 8275 | 0.020 |
Why?
|
Fishes | 1 | 2009 | 563 | 0.020 |
Why?
|
Administration, Inhalation | 1 | 2009 | 1099 | 0.020 |
Why?
|
Oxygen | 1 | 2017 | 4158 | 0.020 |
Why?
|
Mice | 2 | 2014 | 81002 | 0.020 |
Why?
|
Inflammation | 2 | 2018 | 10534 | 0.020 |
Why?
|
Pain Measurement | 1 | 2015 | 3419 | 0.020 |
Why?
|
Prealbumin | 1 | 2007 | 209 | 0.020 |
Why?
|
Administration, Oral | 1 | 2013 | 3909 | 0.020 |
Why?
|
Carrier State | 1 | 2009 | 518 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2015 | 6478 | 0.020 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2007 | 423 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2021 | 13880 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10398 | 0.020 |
Why?
|
Body Mass Index | 2 | 2013 | 12655 | 0.020 |
Why?
|
Mutation | 1 | 2009 | 29658 | 0.020 |
Why?
|
Random Allocation | 1 | 2009 | 2417 | 0.020 |
Why?
|
Recovery of Function | 1 | 2014 | 2924 | 0.010 |
Why?
|
United States | 4 | 2016 | 69573 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9314 | 0.010 |
Why?
|
Genetic Linkage | 1 | 2008 | 2433 | 0.010 |
Why?
|
Oxygen Consumption | 1 | 2009 | 1871 | 0.010 |
Why?
|
Cholesterol | 1 | 2011 | 2900 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2019 | 16646 | 0.010 |
Why?
|
Macaca mulatta | 1 | 2009 | 2384 | 0.010 |
Why?
|
Self Report | 1 | 2013 | 3524 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2011 | 2334 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18349 | 0.010 |
Why?
|
Physical Exertion | 1 | 2004 | 695 | 0.010 |
Why?
|
Health Status Indicators | 1 | 2007 | 969 | 0.010 |
Why?
|
Muscle Contraction | 1 | 2006 | 1240 | 0.010 |
Why?
|
Leg | 1 | 2006 | 1107 | 0.010 |
Why?
|
Heart Defects, Congenital | 1 | 2017 | 4546 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2010 | 2100 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2016 | 15036 | 0.010 |
Why?
|
Androgens | 1 | 2008 | 1270 | 0.010 |
Why?
|
Risk Factors | 2 | 2018 | 71974 | 0.010 |
Why?
|
Lipids | 1 | 2011 | 3307 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2013 | 6963 | 0.010 |
Why?
|
Anxiety Disorders | 1 | 2011 | 2674 | 0.010 |
Why?
|
Adaptation, Physiological | 1 | 2007 | 1310 | 0.010 |
Why?
|
Health Promotion | 1 | 2012 | 2187 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2011 | 3752 | 0.010 |
Why?
|
Fingers | 1 | 2003 | 511 | 0.010 |
Why?
|
Risk | 1 | 2012 | 9684 | 0.010 |
Why?
|
Cell Line | 1 | 2014 | 15987 | 0.010 |
Why?
|
ROC Curve | 1 | 2007 | 3526 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2014 | 14558 | 0.010 |
Why?
|
Depressive Disorder | 1 | 2011 | 3743 | 0.010 |
Why?
|
Exercise Test | 1 | 2006 | 2069 | 0.010 |
Why?
|
Women's Health | 1 | 2008 | 2029 | 0.010 |
Why?
|
Family | 1 | 2009 | 3141 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2012 | 12328 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2018 | 38942 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2016 | 24714 | 0.010 |
Why?
|
Risk Assessment | 1 | 2016 | 23294 | 0.010 |
Why?
|
Rats | 1 | 2011 | 24270 | 0.010 |
Why?
|
Genetic Variation | 1 | 2008 | 6539 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2010 | 21694 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2009 | 18003 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2008 | 15500 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2012 | 11699 | 0.000 |
Why?
|
Myocardial Infarction | 1 | 2008 | 11668 | 0.000 |
Why?
|
Brain | 1 | 2011 | 26345 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2004 | 62693 | 0.000 |
Why?
|